Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Attendo AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 33.55 |
52 Week High | SEK 37.15 |
52 Week Low | SEK 21.06 |
Beta | 1.0 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | -27.73% |
5 Year Change | -57.32% |
Change since IPO | -49.93% |
Recent News & Updates
Recent updates
Shareholder Returns
ATTS | GB Healthcare | GB Market | |
---|---|---|---|
7D | 0% | -3.0% | 0.4% |
1Y | n/a | -19.3% | 7.6% |
Return vs Industry: Insufficient data to determine how ATTS performed against the UK Healthcare industry.
Return vs Market: Insufficient data to determine how ATTS performed against the UK Market.
Price Volatility
ATTS volatility | |
---|---|
ATTS Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 6.4% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 9.9% |
10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: ATTS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ATTS's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | 30,000 | Martin Tiveus | www.attendo.com |
Attendo AB (publ) provides care in Sweden, Finland, Norway, and Denmark. The company offers nursing homes and home care services for older people; and disability care services, which includes group homes and supportive housing, and daily activities including respite care and short-term accommodation. It also provides social psychiatry service; and individual and family care including social-worker supported foster care, crisis and emergency accommodation, HVB-homes, addiction care, and other supportive housing services.
Attendo AB (publ) Fundamentals Summary
ATTS fundamental statistics | |
---|---|
Market cap | SEK 4.67b |
Earnings (TTM) | SEK 139.00m |
Revenue (TTM) | SEK 15.85b |
33.6x
P/E Ratio0.3x
P/S RatioIs ATTS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ATTS income statement (TTM) | |
---|---|
Revenue | SEK 15.85b |
Cost of Revenue | SEK 10.69b |
Gross Profit | SEK 5.15b |
Other Expenses | SEK 5.01b |
Earnings | SEK 139.00m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Oct 24, 2023
Earnings per share (EPS) | 0.86 |
Gross Margin | 32.51% |
Net Profit Margin | 0.88% |
Debt/Equity Ratio | 45.9% |
How did ATTS perform over the long term?
See historical performance and comparison